Botanix Pharmaceuticals Limited
BXPHF
$0.04
$0.0010.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.32% | 38.92% | -2.12% | -73.00% | 2.75% |
| Total Depreciation and Amortization | 0.31% | 5.75% | 2.11% | -1.35% | -2.75% |
| Total Amortization of Deferred Charges | -- | -- | 2.11% | -- | -- |
| Total Other Non-Cash Items | 0.32% | -91.69% | 2.12% | 2,699.34% | 2.75% |
| Change in Net Operating Assets | -- | -- | -2.12% | -- | -- |
| Cash from Operations | -0.32% | 35.62% | -2.12% | -51.27% | 2.75% |
| Capital Expenditure | 0.00% | 98.88% | -2.12% | -108.14% | 2.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.35% | -- | -- | 100.00% | 2.78% |
| Cash from Investing | -0.28% | -130.46% | -2.12% | 77.93% | 2.76% |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | -57.25% | 0.00% | -112.66% | 0.00% |
| Issuance of Common Stock | 0.00% | -99.95% | 0.00% | 8,558.01% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 28.37% | 0.00% | -- | -- |
| Cash from Financing | -0.31% | -104.02% | 2.12% | 15,512.26% | -2.68% |
| Foreign Exchange rate Adjustments | -0.35% | 57.21% | -2.15% | -239.02% | -2.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.32% | -306.08% | 2.12% | 151.54% | 2.75% |